Adnan Khattak

6.4k total citations
45 papers, 616 citations indexed

About

Adnan Khattak is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Adnan Khattak has authored 45 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Immunology. Recurrent topics in Adnan Khattak's work include Cancer Immunotherapy and Biomarkers (20 papers), Colorectal Cancer Treatments and Studies (10 papers) and Immunotherapy and Immune Responses (10 papers). Adnan Khattak is often cited by papers focused on Cancer Immunotherapy and Biomarkers (20 papers), Colorectal Cancer Treatments and Studies (10 papers) and Immunotherapy and Immune Responses (10 papers). Adnan Khattak collaborates with scholars based in Australia, United States and Italy. Adnan Khattak's co-authors include Mohammad Alkaiyat, Christian Rolfo, Abdullah A. Alsharm, Clarissa Mathias, Roselle De Guzman, Evangelia Razis, Hakan Akbulut, Abdul Rahman Jazieh, Layth Mula‐Hussain and Hassan Errihani and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Adnan Khattak

41 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adnan Khattak Australia	12	441	159	126	115	68	45	616
Kelsey L. Corrigan United States	12	296 0.7×	154 1.0×	93 0.7×	97 0.8×	46 0.7×	52	585
Celeste Cagnazzo Italy	12	463 1.0×	105 0.7×	102 0.8×	137 1.2×	74 1.1×	56	758
Daniel E. Meyers Canada	15	412 0.9×	86 0.5×	108 0.9×	179 1.6×	40 0.6×	41	618
Yara Abdou United States	13	415 0.9×	121 0.8×	90 0.7×	113 1.0×	101 1.5×	64	626
John M. Kaczmar United States	16	345 0.8×	104 0.7×	81 0.6×	121 1.1×	34 0.5×	55	627
Abdellatif Benider Morocco	16	498 1.1×	52 0.3×	134 1.1×	106 0.9×	130 1.9×	102	906
Firas Kreidieh Lebanon	11	241 0.5×	61 0.4×	138 1.1×	68 0.6×	99 1.5×	34	528
Max O. Meneveau United States	14	318 0.7×	269 1.7×	68 0.5×	54 0.5×	60 0.9×	35	647
Pelin Cinar United States	13	541 1.2×	44 0.3×	72 0.6×	103 0.9×	141 2.1×	35	658
Alessandro De Toma Italy	10	438 1.0×	70 0.4×	68 0.5×	228 2.0×	36 0.5×	34	563

Countries citing papers authored by Adnan Khattak

Since Specialization

Citations

This map shows the geographic impact of Adnan Khattak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adnan Khattak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adnan Khattak more than expected).

Fields of papers citing papers by Adnan Khattak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adnan Khattak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adnan Khattak. The network helps show where Adnan Khattak may publish in the future.

Co-authorship network of co-authors of Adnan Khattak

This figure shows the co-authorship network connecting the top 25 collaborators of Adnan Khattak. A scholar is included among the top collaborators of Adnan Khattak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adnan Khattak. Adnan Khattak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khattak, Adnan, et al.. (2025). Integrating menstrual hygiene management (MHM) in disaster health response: lessons from 2022 Pakistan floods. SHILAP Revista de lepidopterología. 3(3). 35001–35001.

Khattak, Adnan, Debashis Sarker, Theresa Medina, et al.. (2025). 1515MO Clinical outcomes and PD-L1 expression analyses from a trial of mRNA-4359 plus pembrolizumab in checkpoint inhibitor-resistant/refractory (CPI-R/R) melanoma. Annals of Oncology. 36. S844–S845.

Wong, Vanessa, Shehara Mendis, Rachel Wong, et al.. (2025). Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 24(3). 362–368.

Wong, Hui‐Li, Rachel Wong, Jeremy Shapiro, et al.. (2025). Real world characteristics and outcomes of patients with BRAFV600E-mutant metastatic colorectal cancer in Australia: The COALA project.. Journal of Clinical Oncology. 43(4_suppl). 70–70. 1 indexed citations

Schadendorf, Dirk, Jason J. Luke, Paolo A. Ascierto, et al.. (2024). Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for ImmunoTherapy of Cancer. 12(3). e007501–e007501. 5 indexed citations

Khan, Azim, C. Welman, Andrew Redfern, et al.. (2023). Association of Computed Tomography Measures of Muscle and Adipose Tissue and Progressive Changes throughout Treatment with Clinical Endpoints in Patients with Advanced Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers. 15(5). 1382–1382. 7 indexed citations

Khattak, Adnan, Jeffrey S. Weber, Tarek Meniawy, et al.. (2023). Distant metastasis-free survival results from the randomized, phase 2 mRNA-4157-P201/KEYNOTE-942 trial.. Journal of Clinical Oncology. 41(17_suppl). LBA9503–LBA9503. 50 indexed citations

Aljaidi, Mohammad, et al.. (2023). Maximizing Test Coverage for Security Threats Using Optimal Test Data Generation. Applied Sciences. 13(14). 8252–8252. 11 indexed citations

Hong, Min Hee, Alexander I. Spira, Ki Hyeong Lee, et al.. (2023). 1333P A global phase 1b study of ORIC-114, a highly selective, brain penetrant EGFR and HER2 inhibitor, in patients with advanced solid tumors harboring EGFR Exon 20 or HER2 alterations. Annals of Oncology. 34. S769–S769. 5 indexed citations

10.

Weber, Jeffrey S., Adnan Khattak, Matteo S. Carlino, et al.. (2023). LBA49 mRNA-4157 (V940) individualized neoantigen therapy + pembrolizumab vs pembrolizumab in high-risk resected melanoma: Clinical efficacy and correlates of response. Annals of Oncology. 34. S1288–S1289. 5 indexed citations

11.

Bhave, Prachi, Angela Hong, Serigne Lo, et al.. (2023). Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy. Journal for ImmunoTherapy of Cancer. 11(3). e006629–e006629. 14 indexed citations

12.

Israr, Muhammad, et al.. (2022). Etiology of white pupillary reflex in pediatric age group. Romanian Journal of Ophthalmology. 66(1). 32–35. 3 indexed citations

13.

Tie, Jeanne, Jesse Cohen, Kamel Lahouel, et al.. (2022). 318MO Circulating tumour DNA (ctDNA) dynamics, CEA and sites of recurrence for the randomised DYNAMIC study: Adjuvant chemotherapy (ACT) guided by ctDNA analysis in stage II colon cancer (CC). Annals of Oncology. 33. S683–S683. 8 indexed citations

14.

Wong, Rachel, Lucy Gately, Suzanne Kosmider, et al.. (2021). Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer. Current Problems in Cancer. 46(2). 100793–100793. 1 indexed citations

15.

Degeling, Koen, Hui‐Li Wong, Hendrik Koffijberg, et al.. (2020). Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data. PharmacoEconomics. 38(11). 1263–1275. 3 indexed citations

16.

Jazieh, Abdul Rahman, Hakan Akbulut, Giuseppe Curigliano, et al.. (2020). 1678P_PR The impact of COVID-19 pandemic on cancer care: A global collaborative study. Annals of Oncology. 31. S1209–S1210. 5 indexed citations

17.

Atkinson, Victoria, Adnan Khattak, Andrew Haydon, et al.. (2020). Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma. Journal for ImmunoTherapy of Cancer. 8(2). e001681–e001681. 77 indexed citations

18.

Begbie, Stephen, Suzanne Kosmider, Sumitra Ananda, et al.. (2020). Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status. Clinical Colorectal Cancer. 20(1). e21–e34. 7 indexed citations

19.

Koh, Benjamin, et al.. (2019). Lymphocyte involvement in nivolumab-induced autoimmune myositis. Pathology. 51(5). 555–557. 4 indexed citations

20.

Isaacs, Timothy, Aaron B. Beasley, Adnan Khattak, et al.. (2017). DETECTION OF CHROMOSOMAL ABERRATIONS ASSOCIATED WITH PROGNOSIS OF UVEAL MELANOMA USING CIRCULATING TUMOUR CELLS. Clinical and Experimental Ophthalmology. 45. 61–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact